WHITCOMB RANDALL W 4
4 · Millendo Therapeutics, Inc. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
WHITCOMB RANDALL W
Director
Transactions
- Award
Common Stock
2018-12-07+15,784→ 15,784 total - Award
Stock Option (right to buy)
2018-12-07+21,438→ 21,438 totalExercise: $4.44Exp: 2026-01-27→ Common Stock (21,438 underlying) - Award
Stock Option (right to buy)
2018-12-07+3,720→ 3,720 totalExercise: $16.40Exp: 2028-08-23→ Common Stock (3,720 underlying)
Footnotes (5)
- [F1]Received in exchange for 212,163 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger").
- [F2]Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F3]Received in connection with the Merger in exchange for a stock option to acquire 288,152 shares of Millendo common stock for $0.33 per share.
- [F4]Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F5]Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share.